<DOC>
	<DOCNO>NCT00109486</DOCNO>
	<brief_summary>The purpose study assess effect child seasonal and/or perennial allergic rhinitis GW685698X aqueous nasal spray ( versus vehicle placebo nasal spray ) growth use knemometry .</brief_summary>
	<brief_title>Safety Study To Assess Growth In Children With Seasonal Allergic And/Or Perennial Allergic Rhinitis Treated With GW685698X Aqueous Nasal Spray Or Placebo Nasal Spray</brief_title>
	<detailed_description />
	<mesh_term>Rhinitis , Allergic</mesh_term>
	<mesh_term>Rhinitis</mesh_term>
	<mesh_term>Rhinitis , Allergic , Perennial</mesh_term>
	<criteria>Inclusion criterion : Females ( age 6 11 ) begin menses . Males ( age 6 12 ) . Tanner Stage 1 . History SAR ( Seasonal Allergic Rhinitis ) PAR ( Perennial Allergic Rhinitis ) least one year either current level allergic rhinitis symptoms warrant treatment and/or expect symptom majority study period . Positive skin test appropriate seasonal perennial allergen . Exclusion criterion : History abnormal growth gross malnutrition . Clinically significant laboratory abnormality . History condition may substantially affect growth . Historical current evidence clinically significant , uncontrolled disease body system . Any asthma mild , intermittent asthma control shortacting , betaagonists . Recent major surgery and/or trauma leg . History adrenal insufficiency . Current prior treatment medication may potential ongoing effect linear growth . Use corticosteroid , route , within 4 week prior Visit 1 . Any nasal condition deformity would impair nasal breathe deposition medication . Physical impairment would affect subject 's ability participate study .</criteria>
	<gender>All</gender>
	<minimum_age>6 Years</minimum_age>
	<maximum_age>12 Years</maximum_age>
	<verification_date>September 2016</verification_date>
	<keyword>GW685698X</keyword>
	<keyword>seasonal allergic rhinitis</keyword>
	<keyword>perennial allergic rhinitis</keyword>
	<keyword>knemometry</keyword>
	<keyword>child</keyword>
</DOC>